Published in Indian J Anaesth on March 01, 2015
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA (1997) 3.87
Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab (2001) 2.98
Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. N Engl J Med (2003) 2.88
Effect of nitrous oxide on plasma homocysteine and folate in patients undergoing major surgery. Br J Anaesth (2008) 2.18
Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) (1994) 2.14
Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab (2001) 1.93
Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia. Anesthesiology (2008) 1.66
Cushing's syndrome. Lancet (2001) 1.48
Cushing's syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet (1982) 1.45
Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol (1996) 1.34
Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med (2007) 1.30
Nitrous oxide-induced increased homocysteine concentrations are associated with increased postoperative myocardial ischemia in patients undergoing carotid endarterectomy. Anesth Analg (2000) 1.23
The use of intraoperative nitrous oxide leads to postoperative increases in plasma homocysteine. Anesth Analg (1998) 1.19
Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function. Anesthesiology (2008) 1.15
Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab (2002) 1.10
Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutr (1996) 1.00
Effect of nitrous oxide exposure during surgery on the homocysteine concentrations of children. Anesthesiology (2012) 0.99
Hyperhomocysteinemia in patients with Cushing's syndrome. J Clin Endocrinol Metab (2004) 0.97
Reversible nitrous oxide myelopathy and a polymorphism in the gene encoding 5,10-methylenetetrahydrofolate reductase. Br J Anaesth (2005) 0.84